Experian helps Leukaemia Research boost donations

LONDON – Charity Leukaemia Research has selected an Experian analytical tool to boost donor contributions after trials pushed average values up by 26%.

The national research charity devoted to leukaemia and related blood disorders is to use Experian's Prime Performance Modelling as part of its strategy to acquire new donors.

Experian's National Canvasse and Canvasse Lifestyle databases will add to Leukemia Research's own. Applying Prime Performance Modelling's techniques will then allow the charity to most effectively target responsive donors.

Richard Hogg, Leukaemia Research's managing director, said: "In Prime Performance Modelling, we have a tremendously powerful targeting tool at our disposal.

"The level of insight provided... will enable us to greatly enhance the return from our donor acquisition campaigns."

If you have an opinion on this or any other issue raised on Brand Republic, join the debate in the .

You have

[DAYS_LEFT] Days left

of your free trial

Subscribe now

Get a team licence 

 Give your teams unrestricted access to in-depth editorial analysis, breaking news and premium reports with a bespoke subscription to ±±¾©Èü³µpk10.

Find out more

Market Reports

Get unprecedented new-business intelligence with access to ±±¾©Èü³µpk10’s new Market Reports.

Find out more

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an Alert Now